Skip to main content

Table 3 Genotyping and allele frequency and haplotype of PD-1.5 and PD-1.9 SNP in patients and controls.

From: Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population

SNP

Alleles

Patients (%)

Controls (%)

OR (95% CI)

PD-1.5

CC

34 (42.0)

53 (40.8)

 
 

CT

40 (49.4)

51 (39.2)

 
 

TT

7 (8.6)

26 (20.0)

 
 

C

108 (66.7)

158 (60.8)

 
 

T

54 (33.3)

102 (39.2)

 

PD-1.9

TTa

2 (2.5)

3 (2.3)

 
 

CT

30 (37.5)

12 (9.2)

 
 

CCb,c

49 (60.5)

115 (88.5)

 
 

Td

34 (21.0)

18 (6.9)

1.89 (1.483–2.408)

 

C

128 (79.0)

242 (93.1)

 

PD-1.5/1.9 (haplotype)

CTe

31 (19.1)

14 (5.4)

1.83 (1.559–2.521)

 

CC

77 (47.5)

144 (55.4)

 
 

TT

3 (1.9)

4 (1.5)

 
 

TC

51 (31.5)

98 (37.7)

 
  1. SNP, single-nucleotide polymorphism; OR, odds ratio; CI, confidence interval. ap = 0.000, χ2 test, in PD-1.9 SNP ; bp = 0.638, χ2 test, CC versus TT; cp = 0.000, χ2 test, CC versus CT ; dp = 0.000, χ2 test, in PD-1.9 SNP; ep = 0.000, χ2 test, in PD-1.5/1.9 haplotype analysis.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us